Fundz

NVENTRIC raises $22.6M in a pre-IPO round led by multiple investors to boost global expansion and advance its Kosdaq listing.

PRIVATEJun 10, 2026

Amount Raised

$22.6 Million

Round Type

Venture

South KoreaManufacturingBiotechnologyHealth CareMedicalMedical Device

Investors

Heungkuk SecuritiesFlexus PartnersPacific CapitalQuad Asset ManagementLB InvestmentHB InvestmentAJU IB InvestmentIps VenturesShinhan CapitalShinhan Venture InvestmentScale Up PartnersMoneyball PartnersMoneyball VenturesLoftyrock Investment

Description

NVENTRIC has successfully closed a pre-IPO funding round of approximately $22.6 million. The round included fourteen new institutional backers, with significant participation from existing investors like Shinhan Capital. The company plans to use the funds for R&D and expanding its manufacturing infrastructure. NVENTRIC is also gearing up for a Kosdaq listing, marking a significant step in its growth trajectory.

Quick answer

NVENTRIC raised $22.6 Million in a funding round, dated June 10, 2026. Investors: Heungkuk Securities, Flexus Partners, Pacific Capital, Quad Asset Management, LB Investment, HB Investment, AJU IB Investment and Ips Ventures. NVENTRIC is based in South Korea.

How much did NVENTRIC raise?
NVENTRIC raised $22.6 Million in a funding round on June 10, 2026.
Who invested in NVENTRIC?
Heungkuk Securities, Flexus Partners, Pacific Capital, Quad Asset Management, LB Investment, HB Investment, AJU IB Investment and Ips Ventures are named as investors in this round.
What does NVENTRIC do?
NVENTRIC is a South Korean medical device company that specializes in vascular intervention.
Where is NVENTRIC based and how big is it?
NVENTRIC is based in South Korea. Fundz records about 32 employees.
Who are the decision-makers at NVENTRIC?
Fundz holds 1 contact at NVENTRIC, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as NVENTRIC that raised within 45 days of this round, from Fundz verified event records.

  • QTREX Quantum Ltd raised $10M on July 22, 2026.
  • Endo Tools Therapeutics raised $23M (Series C) on July 16, 2026.
  • Biobot Surgical raised $15M (Funding Round) on June 29, 2026.
  • IceCure Medical raised $17M on June 17, 2026.
  • Icarus Medical raised $7.2M (Series A) on June 17, 2026.
  • FesariusTherapeutics raised $20M (Series A) on June 10, 2026.

Who to call at NVENTRIC, and when

A new round usually means NVENTRIC is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NVENTRIC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NVENTRIC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NVENTRIC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NVENTRIC

Location

South Korea

About

NVENTRIC is a South Korean medical device company that specializes in vascular intervention. It has developed neurovascular devices, including the EVOGLIDE distal access catheter and the ULTRIVA stent retriever, which are designed for the treatment of ischemic stroke. The company has achieved significant revenue growth and is preparing for a Kosdaq listing. NVENTRIC plans to use its recent funding to enhance R&D and expand manufacturing capabilities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NVENTRIC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSungwoo M., CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for NVENTRIC's next move

See what Strategic adds

NVENTRIC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.